Patent · US Active

Lipidated amide-based insulin prodrugs

US10385107B2 · kind B2 · utility

0Cited by
18References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 23, 2015
Grant dateAug 20, 2019
Priority date
Expiry dateSep 23, 2035

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K47/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Prodrug formulations of insulin and insulin analogs are provided wherein the insulin peptide has been modified by an amide bond linkage of a dipeptide prodrug element. The prodrugs disclosed herein have extended half-lives and are converted to the active form at physiological conditions through a non-enzymatic reaction driven by chemical instability.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.